Nivolumab Plus Ipilimumab for Treatment-Naïve Metastatic Uveal Melanoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Nivolumab Plus Ipilimumab for Treatment-Naïve Metastatic Uveal Melanoma: An Open-Label, Multicenter, Phase II Trial by the Spanish Multidisciplinary Melanoma Group (GEM-1402)
J. Clin. Oncol 2021 Jan 08;[EPub Ahead of Print], JM Piulats, E Espinosa, L de la Cruz Merino, M Varela, L Alonso Carrión, S Martín-Algarra, R López Castro, T Curiel, D Rodríguez-Abreu, M Redrado, M Gomà, AJ Rullán, A Calvo González, A Berrocal-JaimeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.